Want to see TSE:ASEP full AI Analyst Report?
ASEP Stock Chart & Stats
C$0.31
-C$0.03(-33.33%)
At close: 4:00 PM EST
C$0.31
-C$0.03(-33.33%)
Day’s Range― - ―
52-Week RangeC$0.06 - C$0.50
Previous CloseN/A
Volume0.00
Average Volume (3M)7.45K
Market Cap
C$2.06M
Enterprise ValueC$3.93
Total Cash (Recent Filing)C$76.32K
Total Debt (Recent Filing)C$177.50K
Price to Earnings (P/E)―
Beta-1.15
Next Earnings
Dec 01, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.36
Shares Outstanding15,873,520
10 Day Avg. Volume12,443
30 Day Avg. Volume7,446
Financial Highlights & Ratios
PEG Ratio0.01
Price to Book (P/B)1.24
Price to Sales (P/S)8.56
P/FCF Ratio-2.83
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Revenue GrowthPositive revenue growth indicates the company is expanding its commercial activity, even from a modest base. If sustained, this can improve operating leverage, support greater market adoption of its diagnostic and therapeutic offerings, and help move the business toward scale.
Low Balance-Sheet LeverageVery low leverage limits balance-sheet financial risk and reduces the burden of mandatory debt servicing for this early-stage biotech. That provides greater flexibility to direct available resources toward development and commercialization rather than servicing substantial borrowings.
Improving Loss ProfileThe narrowing of operating losses and improvement in free cash flow suggest some progress in cost control or cash-use timing. Although the company remains unprofitable, continued improvement could strengthen its path toward more efficient operations and eventual financial sustainability.
Bears Say
Persistent Cash BurnOngoing negative operating and free cash flow means the business is not yet funding itself through operations. Continued cash burn can constrain investment in development and commercialization, while increasing the need for financing before revenue reaches a more supportive scale.
Severe UnprofitabilityNegative gross profit and an extremely negative net margin show that current revenue is far below the level needed to cover the company’s cost structure. This weak earnings base limits internal funding capacity and makes a durable transition to profitability dependent on substantial improvement.
Shrinking Equity BaseA declining equity base indicates that accumulated losses are eroding shareholder capital and that the company is not yet financially self-funding. If this persists, additional capital may be needed to sustain operations, potentially reducing financial flexibility and increasing dilution pressure.
ASEP Medical Holdings Inc News
ASEP FAQ
What was ASEP Medical Holdings Inc’s price range in the past 12 months?
ASEP Medical Holdings Inc lowest stock price was C$0.06 and its highest was C$0.50 in the past 12 months.
What is ASEP Medical Holdings Inc’s market cap?
ASEP Medical Holdings Inc’s market cap is C$2.06M.
When is ASEP Medical Holdings Inc’s upcoming earnings report date?
ASEP Medical Holdings Inc’s upcoming earnings report date is Dec 01, 2026 which is in 66 days.
How were ASEP Medical Holdings Inc’s earnings last quarter?
ASEP Medical Holdings Inc released its earnings results on Jun 30, 2026. The company reported -C$0.043 earnings per share for the quarter.
Is ASEP Medical Holdings Inc overvalued?
According to Wall Street analysts ASEP Medical Holdings Inc’s price is currently Overvalued.
Does ASEP Medical Holdings Inc pay dividends?
ASEP Medical Holdings Inc does not currently pay dividends.
What is ASEP Medical Holdings Inc’s EPS estimate?
ASEP Medical Holdings Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does ASEP Medical Holdings Inc have?
ASEP Medical Holdings Inc has 15,873,520 shares outstanding.
What happened to ASEP Medical Holdings Inc’s price movement after its last earnings report?
ASEP Medical Holdings Inc reported an EPS of -C$0.043 in its last earnings report. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of ASEP Medical Holdings Inc?
Currently, no hedge funds are holding shares in TSE:ASEP
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
ASEP Medical Holdings Inc
Asep Medical Holdings Inc. is dedicated to advancing medical solutions, primarily through its subsidiary, ASEP Medical Inc. The company's core focus involves pioneering an early diagnostic method for Sepsis, as well as developing innovative peptide-based therapeutic treatments applicable to a variety of medical conditions. Established in 2020, this Vancouver, Canada-based firm was formerly known as Trenchant Life Sciences Investment Corp. before adopting its present identity.
Technical Analysis
―
Bright Minds Biosciences
―
MYND Life Sciences
―
Universal Ibogaine Inc
―
Mindbio Therapeutics Corp.
―